STERIS (STE) – Investment Analysts’ Weekly Ratings Updates

Several brokerages have updated their recommendations and price targets on shares of STERIS (NYSE: STE) in the last few weeks:

  • 2/9/2024 – STERIS had its “overweight” rating reaffirmed by analysts at Stephens. They now have a $250.00 price target on the stock.
  • 2/8/2024 – STERIS had its “market outperform” rating reaffirmed by analysts at JMP Securities. They now have a $265.00 price target on the stock.
  • 2/7/2024 – STERIS was upgraded by analysts at TheStreet from a “c+” rating to a “b” rating.
  • 2/6/2024 – STERIS is now covered by analysts at KeyCorp. They set an “overweight” rating and a $253.00 price target on the stock.

STERIS Trading Up 0.3 %

STE opened at $224.94 on Tuesday. The stock has a market capitalization of $22.23 billion, a price-to-earnings ratio of 39.39 and a beta of 0.80. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.43 and a quick ratio of 1.49. The business has a fifty day moving average price of $216.56 and a 200 day moving average price of $218.18. STERIS plc has a 12 month low of $173.21 and a 12 month high of $254.00.

STERIS (NYSE:STEGet Free Report) last released its quarterly earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.17 by $0.05. STERIS had a return on equity of 13.67% and a net margin of 10.48%. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter last year, the company posted $2.02 earnings per share. The business’s revenue was up 14.8% on a year-over-year basis. Sell-side analysts expect that STERIS plc will post 8.67 earnings per share for the current fiscal year.

STERIS Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Thursday, February 22nd. This represents a $2.08 annualized dividend and a yield of 0.92%. STERIS’s dividend payout ratio (DPR) is currently 36.43%.

Institutional Investors Weigh In On STERIS

A number of hedge funds and other institutional investors have recently modified their holdings of STE. 1832 Asset Management L.P. bought a new stake in shares of STERIS in the first quarter worth $25,000. Millburn Ridgefield Corp acquired a new stake in STERIS in the 3rd quarter valued at about $25,000. Catalyst Capital Advisors LLC purchased a new stake in STERIS during the third quarter valued at about $25,000. West Tower Group LLC purchased a new stake in STERIS during the second quarter valued at about $32,000. Finally, VisionPoint Advisory Group LLC acquired a new position in shares of STERIS in the 4th quarter valued at about $34,000. 92.91% of the stock is currently owned by hedge funds and other institutional investors.

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Featured Stories

Receive News & Ratings for STERIS plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS plc and related companies with's FREE daily email newsletter.